CARSS 2017 Report Executive Summary | Home

Facebook  Twitter  LinkedIn

Members Area
Resources Resources Open
Chapters Chapters Close
Site Map Site Map Open
Home

IPAC in Mental Health WebinarAntibiotic-Resistant Organisms Hand Hygiene E-Learning ToolMentorship Program

Coming Events

News and Journal Articles

Twitter

You can follow us on Twitter or Facebook; our posts are shared on both sites.
TwitterFacebook

Welcome to IPAC Canada*

*Google Translate provides 'IAPC Canada' as the acronym which is used throughout this French website. The true acronym is 'PCI Canada'; however, the website translation cannot be changed.

IPAC Canada is a multidisciplinary member-based association committed to public wellness and safety by advocating for best practices in infection prevention and control in all settings.


Latest News and Events

Back to News
CARSS 2017 Report Executive Summary

The Canadian Antimicrobial Resistance Surveillance System (CARSS) - 2017 Report executive summary is now available on Canada.ca.  The full PDF technical report will be available in both official languages to download from the website by mid-December.  In the interim, both the English and French PDF is available upon request by emailing carss-scsra@phac-aspc.ca

English: https://www.canada.ca/en/public-health/services/publications/drugs-health-products/canadian-antimicrobial-resistance-surveillance-system-2017-report-executive-summary.html

French: https://www.canada.ca/fr/sante-publique/organisation/mandat/a-propos-agence/organismes-consultatifs-externes/liste/groupe-consultatif-experts-resistance-antimicrobiens.html

This year’s report provides a snapshot of 2015 and 2016 antimicrobial resistance (AMR) and use (AMU) data from the different Public Health Agency of Canada (PHAC) surveillance systems and its national laboratory reference services. 

Although the overall level of AMR in Canada is similar or lower than rates reported by other developed countries, there are some areas of concern.  Upward trends were seen in the rate of methicillin-resistant Staphylococcus aureus blood stream infection (BSI) in pediatric hospitals and the rate of vancomycin-resistant Enterococcus BSI in adults.   In addition, the rate of drug-resistant gonorrhea increased between the years 2014 and 2015.  There also remain significant data gaps that prevent our ability to provide a comprehensive picture of the current situation and emerging risks of AMR in Canada. Strengthening the surveillance of AMR and AMU in humans and animals is a priority for PHAC and the yearly CARSS Report serves to highlight the attained progress and future steps in addressing these gaps. 

IPAC Canada Corporate Members

Ansell Chem-aqua Class1inc HealthCentric ImperialSurgical
Bronze:
Nosotech
SciCan
Stevens
Steris
Wood Wyant
Arjo Huntleigh
BRONZE:
Platinum Clorox Diversey Gojo Virox
Platinum:
Hygie
3M Deb Med
Sage Products
HandyMetrics
WebberTraining
Silver:
The placement of corporate logos does not imply advertisement or endorsement of a company's products or services. IPAC Canada is not responsible for information found on any external website reached through corporate links.